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Introduction. Cotard syndrome is a rare condition characterized by nihilistic delusions concerning body or life that can be found
in several neuropsychiatry conditions. It is typically associated with depressive symptoms. Method. We present a case of Cotard
syndrome without depressive symptoms in the context of known paranoid schizophrenia. A literature review of Cotard syndrome
in schizophrenia was performed. Results. Although there are few descriptions of this syndrome in schizophrenia, patients usually
present depressive mood and psychomotor retardation, features not seen in our patient. Loss of the sense of the inner self, present
in schizophrenia, could explain patient’s symptomatology but neurobiological bases of this syndrome remain unclear. Conclusion.
Despite not being considered in actual classifications, Cotard syndrome is still relevant and psychiatric evaluation is critical to
diagnosing and treating this condition in psychiatric patients.
1. Introduction
Cotard syndrome (CS) has been described by Jules Cotard
(1880) as a nihilistic delusion, whichmay range fromnegation
of existence of parts of the body to delusion of being
dead and negation of self-existence. This syndrome can be
found in numerous psychiatric or neurologic conditions,
such as mood disorders, schizophrenia and other psychotic
disorders, dissociative disorders, central nervous system
(CNS) infections, cerebrovascular disease, CNS neoplasm,
and traumatic brain injury [1–3]. CS typically affects middle-
aged or older people and the typical picture also includes
depressive mood, which is present in approximately 90% of
cases described in the literature [1]. Presentation at younger
ages has been described as being associated with an increased
risk of bipolar disorder [2].
We report on a patient with known schizophrenia and
history of opioid abuse that developed a CS one year after
medication dropout. To our knowledge, only few cases have
been described reporting CS without depressive symptoms.
2. Case Report
Our patient was a 42-year-old male who was treated for
paranoid schizophrenia at our psychiatric department for 10
years. He had also a history of opioid abuse, being abstinent
for 4 years. He was medicated with haloperidol decanoate
100mg intramuscularly (i.m.) every 4weeks but discontinued
treatment one year after the current admission.
He was brought to the emergency room (ER) by his
cousin for behavioural alterations and paranoid speech.
Progressively over a 2-month period he had become more
isolated and developed paranoid thoughts, reporting that
someone had captured him and controlled his behavior and
thoughts. He also showed nihilistic delusions concerning
his body (“my heart does not beat,” “my stomach are being
destroyed and I’m being fed by tube,” “my palate disappeared”
and “I have no blood”) and stated he was going to die that
day. He presented restricted affect but psychomotor activity
was enhanced andmoodwas euthymic. Physical examination
was normal. Laboratory assessment (complete blood count,
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electrolytes, creatinine levels, and thyroid hormones) was
within normal values. Urine drug screen test was negative
and blood ethanol levels were undetectable. Brain CT did not
demonstrate any pathology.
He was admitted to our inpatient psychiatric unit and
medicated with paliperidone 12mg/d and lorazepam 5mg/d.
As the patient was initially reluctant to take medication,
haloperidol 10–15mg/d was administered intramuscularly.
Due to the extrapyramidal side effects of haloperidol, biperi-
den was added, 4mg/d. After one week of treatment, he
started to improve his behavior and delusional ideation
became less intense. The patient was discharged 24 days after
admission in a state of full remission, as paranoid and nihilis-
tic delusions completely disappeared. After discharge he
maintained treatment with paliperidone 12mg/d and during
the 6-month follow-up no somatic or psychotic symptoms
were reported by the patient or detected during clinical
evaluations. Thus, the diagnosis of paranoid schizophrenia
was maintained.
3. Discussion
In this case report, we present an uncommon form of
CS as the patient did not display any depressive symp-
toms associated with his nihilistic delusions. The described
patient suffered from an exacerbation of his known paranoid
schizophrenia, which responded to monotherapy with an
atypical antipsychotic, achieving full remission of delusions.
In fact, CS is typically associated with depressive mood
and psychomotor inhibition [1] and treatment usually
involves antidepressants, mood stabilizers, and/or electro-
convulsive therapy (ECT) [3]. Even in the context of mood
disorders, this syndrome is rare. A review of 479 psychiatric
patients admitted to inpatient treatment inMexico, including
150 suffering from schizophrenia, identified 3 cases of CS
(0.62%) but none of them in the context of schizophrenia
[4]. Despite being well known that nihilistic delusions can
occur in schizophrenia, only few single cases or small series
report this occurrence [5–9]. In a recent review of 346 cases of
schizophrenia, CS could be diagnosed in three cases (0.87%),
all associated with loss of energy [10]. Interestingly, this
contrasts with enhanced psychomotor activity observed in
our patient.
Apart from restricted affect, our patient did not display
any other alteration of mood and emotions. Indeed, affective
flattening and abnormal affective processing, mediated by
dysfunctional flow of information from sensory cortices
to the limbic system, were suggested to be related with
monothematic delusions in schizophrenia [11]. In addition,
abnormalities in nondominant frontal, temporal, and parietal
lobes, areas known to be affected by schizophrenia, have also
been related with CS [3].
Some authors considered nihilist delusions as an extreme
manifestation of the topic of death [10]. However, considering
the cooccurrence of Cotard and Capgras syndromes (the lat-
ter is themost commonmisidentification syndrome) [5, 7, 12,
13], it could be conceptualized that both monothematic and
bizarre delusions are related with loss of the sense of the inner
self that is core and typical of schizophrenia. Alternately, CS
can be conceptualized as a dysfunction of egocentric mind-
representing system (as asomatognosia is conceptualized as
damage of the egocentric body-representing system) [14].
This phenomenon can be mediated by dysfunction of insular
cortex, an area that plays a central role in the conscious
awareness of internal sensations and that is known to be
affected by stress [15, 16].
Although CS is not a psychiatric diagnosis but a feature of
several neurological and psychiatric conditions, psychiatrists
should be aware of this uncommon psychotic phenomenon
to prompt diagnosing, describing, and treating according to
the best evidence.
4. Conclusion
Despite not being considered in actual classifications, Cotard
syndrome is still relevant and clinical recognition is critical to
diagnosing and treating this condition in psychiatric patients.
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